<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the search for <z:chebi fb="0" ids="26537">retinoids</z:chebi> active against Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), we found that the arotinoid mofarotene (Ro 40-8757) induced strong antiproliferative and apoptotic responses in most established <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines as well as in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Ro 40-8757-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> is associated with <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane depolarization, activation of caspase-3 and -9, and enhanced production of reactive oxygen species </plain></SENT>
<SENT sid="2" pm="."><plain>These effects were related to a transient drop in intracellular ATP content, probably favored by a downregulation of <z:chebi fb="0" ids="16908">NADH</z:chebi> dehydrogenase subunit-1, a component of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> respiratory chain (MRC) Complex I </plain></SENT>
<SENT sid="3" pm="."><plain>Inhibition of MRC with thenoyltrifluoroacetone suppressed both the ATP recovery and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, confirming that the effects of Ro 40-8757 are mediated by changes in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function </plain></SENT>
<SENT sid="4" pm="."><plain>Compared to EBV-negative lines, EBV-carrying <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> were more resistant to Ro 40-8757-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> and ectopic LMP-1 expression increased the resistance of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells to Ro 40-8757-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, probably through bcl-2 upregulation </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, we also show that 2-methoxyoestradiol, an inhibitor of the scavenger enzymes <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutases, enhanced Ro 40-8757-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>These findings provide the rationale for evaluating the clinical efficacy of Ro 40-8757 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> patients and suggest that the combination of Ro 40-8757 with inhibitors of scavenger enzymes may be a promising therapeutic approach for this aggressive <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>